Browsing: PET

Top Line: How do fluciclovine- versus PSMA-tagged PET imaging compare for biochemically-recurrent prostate cancer?The Study: Today we’re getting beyond conjecture.…

Top Line: Does invasive mediastinal staging reduce the risk of out-of-field failure in patients with locally advanced NSCLC staged with…

Top Line: How accurate is PET-CT at identifying residual nodal disease after definitive chemoradiation for head and neck squamous cell…

The list of molecular imaging agents for prostate cancer continues to expand. This study evaluated the diagnostic performance of Ga68-RM2…

Top Line: Is post-treatment PET prognostic of treatment outcomes for anal cancer?The Study: FDG-PET is often used in the initial…

Top Line: Is FDG-PET useful in staging patients with locally advanced breast cancer? The Study: Body imaging plays a limited…

The EMPIRE-1 trial showed that incorporating fluciclovine PET/CT into treatment planning for salvage prostate radiation improved disease-free survival. This secondary…